Updated/Latest Pharmacotherapeutics for Advanced Practice Nurse Prescribers 5th Edition by Woo and Robinson 2025–2026 Comprehensive Test Bank Questions and Answers for Advanced Pharmacology Nurse Practitioner Prescribing Examination Preparation Clinical D

Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 5th edition Woo Robinson Test Bank FT L L
FT FT L FT L FT L FT L L
FT FT L FT L L
FT L
FT




Chapter 1. The Role of the Nurse Practitioner as Prescriber
FT L FT L L
FT FT L L
FT L
FT FT L FT L FT L




FT Multiple Choice
L FT L




Identify the choice that best completes the statement or answers the question.
FT L FT L L
FT FT L FT L L
FT L
FT FT L L
FT FT L FT L




F T L 1. Nurse practitioner prescriptive authority is regulated by:
FTL FT L FT L FT L FT L FT L F T L



1. The National Council of State Boards of Nursing
FT L FT L FT L FT L L
FT FT L FT L



2. The U.S. Drug Enforcement AdministrationFT L L
FT FT L L
FT




3. The State Board of Nursing for each state
FT L L
FT L
FT FTL FT L FT L FT L



4. The State Board of Pharmacy FT L FT L FT L FT L




F T L 2. The benefits to the patient of having an Advanced Practice Registered Nurse (APRN)
FT L FT L L
FT L
FT L
FT FT L FT L FT L FT L FT L L
FT L
FT L
FT




prescriber include:
L
T
F FT L



1. Nurses know more about Pharmacology than other prescribers because they take itFT L L
FT L
FT FT L FT L L
FT L
FT L
FT L
FT L
FT L
T
F




both in their basic nursing program and in their APRN program.
L
FT FT L FT L L
FT FT L L
FT FT L FT L FT L FT L FT L



2. Nurses care for the patient from a holistic approach and include the patient inFT L L
FT L
FT L
FT FT L L
FT L
FT FT L L
FT L
FT L
FT FT L L
FT




decision making regarding their care.
L
FT FT L FT L FT L FT L



3. APRNs are less likely to prescribe narcotics and other controlled substances. L
FT L
FT FT L FT L L
FT FT L L
FT L
FT L
FT L
FT




4. APRNs are able to prescribe independently in all states, whereas a physician’s L
FT FT L FT L FT L L
FT FT L L
FT FT L L
FT L
FT L
FT




assistant needs to have a physician supervising their practice.
L
FT L
FT FT L L
FT FT L FT L FT L FT L L
FT




F T L 3. Clinical judgment in prescribing includes:
FTL FT L FT L FT L F T L



1. Factoring in the cost to the patient of the medication prescribed FT L FT L L
FT L
FT FT L L
FT L
FT FT L FT L FT L



2. Always prescribing the newest medication available for the disease process FT L L
FT FT L L
FT L
FT FT L L
FT L
FT FT L



3. Handing out drug samples to poor patients FT L FT L L
FT FT L L
FT FT L



4. Prescribing all generic medications to cut costs L
FT L
FT FT L L
FT FT L L
FT




F T L 4. Criteria for choosing an effective drug for a disorder include:
FTL FT L FT L FT L FT L FT L L
FT FT L L
FT F T L



1. Asking the patient what drug they think would work best for them L
FT FT L FT L L
FT FT L L
FT FT L FT L L
FT L
FT L
FT




2. Consulting nationally recognized guidelines for disease management L
FT FT L FT L FT L L
FT L
FT




3. Prescribing medications that are available as samples before writing a prescription FT L FT L L
FT L
FT FT L FT L FT L L
FT L
FT L
FT




4. Following U.S. Drug Enforcement Administration guidelines for prescribing L
FT L
FT FT L L
FT L
FT L
FT FT L




F T L 5. Nurse practitioner practice may thrive under health-care reform because of:
FTL FT L FT L FT L F T L FT L FT L FT L L
FT F T L



1. The demonstrated ability of nurse practitioners to control costs and improve patient
L
FT L
FT L
FT L
FT L
FT L
FT L
FT L
FT L
FT L
FT T
F L



outcomes L
FT




2. The fact that nurse practitioners will be able to practice independently
L
FT FT L FT L FT L L
FT L
FT FT L FT L L
FT L
FT




3. The fact that nurse practitioners will have full reimbursement under health-
L
FT L
FT L
FT L
FT FT L FT L FT L L
FT L
FT L
FT




care reform FT L



4. The ability to shift accountability for Medicaid to the state level
L
FT FT L L
FT FT L L
FT L
FT L
FT FT L FT L L
FT

,Chapter 1. The Role of the Nurse Practitioner as Prescriber
L
FT L
FT L
FT L
FT L
FT L
FT L
FT L
FT FT L



Answer Section
FT L FT L




MULTIPLE CHOICE FT L




1. ANS: L
FT 3 PTS: 1
2. ANS: L
FT 2 PTS: 1
3. ANS: L
FT 1 PTS: 1
4. ANS: L
FT 2 PTS: 1
5. ANS: L
FT 1 PTS: 1

,Chapter 2. Review of the Basic Principles of Pharmacology
L
FT FT L L
FT FT L FT L FT L FT L FT L




Multiple Choice T
F L




Identify the choice that best completes the statement or answers the question.
FT L FT L L
FT L
FT L
FT FT L FT L FT L FT L FT L L
FT




F T L 1. A patient’s nutritional intake and laboratory results reflect hypoalbuminemia. This is critical
FTL FT L FT L L
FT FT L L
FT L
FT FT L L
FT FT L FT L L
FT




to prescribing because:
FT L L
FT FT L



1. Distribution of drugs to target tissue may be affected. FT L FT L FT L FTL FT L FT L FT L L
FT




2. The solubility of the drug will not match the site of absorption. L
FT L
FT FT L L
FT FTL FT L FT L FT L FT L FTL F T L



3. There will be less free drug available to generate an effect. FT L L
FT L
FT FT L L
FT FT L L
FT L
FT FTL FT L



4. Drugs bound to albumin are readily excreted by the kidneys. L
FT L
FT L
FT FT L FT L FT L L
FT FT L FT L




F T L 2. Drugs that have a significant first-pass effect:
L
FT FT L FT L FT L FT L FT L F T L



1. Must be given by the enteral (oral) route only L
FT L
FT FT L FT L FT L FTL FT L FT L



2. Bypass the hepatic circulation L
FT L
FT L
FT




3. Are rapidly metabolized by the liver and may have little if any desired action
L
FT FT L FT L FT L FT L L
FT FT L L
FT L
FT FT L FT L L
FT L
FT




4. Are converted by the liver to more active and fat-soluble forms L
FT FT L FT L FT L L
FT FTL FTL FT L FT L L
FT




F T L F T L 3. The route of excretion of a volatile drug will likely be the:
FT L FT L FT L FT L FT L FT L FT L FT L FT L L
FT FT L F T L



1. Kidneys
2. Lungs
3. Bile and feces L
FT L
FT




4. Skin

F T L 4. Medroxyprogesterone (Depo Provera) is prescribed intramuscularly (IM) to create a
FTL FT L L
FT FT L L
FT FT L L
FT L
FT L
FT L
FT




L
T
Fstorage reservoir of the drug. Storage reservoirs: FT L FT L L
FT FT L FT L FT L


1. Assure that the drug will reach its intended target tissue L
FT L
FT FT L FT L L
FT FT L FT L L
FT FT L



2. Are the reason for giving loading doses FT L FT L FT L L
FT FT L FT L



3. Increase the length of time a drug is available and active FT L L
FT FT L FT L FT L FT L L
FT FT L FT L FT L



4. Are most common in collagen tissues L
FT FT L FT L L
FT FT L




F T L F T L 5. The NP chooses to give cephalexin every 8 hours based on knowledge of the drug’s:
FT L FT L L
FT FTL L
FT L
FT L
FT FT L FT L F T L FT L FT L FT L FT L F T L



1. Propensity to go to the target receptor FT L FT L L
FT FT L FT L FTL



2. Biological half-life L
FT




3. Pharmacodynamics
4. Safety and side effects L
FT L
FT FT L




F T L 6. Azithromycin dosing requires that the first day’s dosage be twice those of the other 4 days of
FT L FT L L
FT FT L FT L FT L L
FT L
FT L
FT FT L L
FT L
FT L
FT L
FT L
FT L
FT L
FT




the prescription. This is considered a loading dose. A loading dose:
FT L FT L FT L FT L FT L FT L FT L FT L L
FT FT L FT L



1. Rapidly achieves drug levels in the therapeutic range FT L FT L FT L FT L FT L L
FT FT L



2. Requires four- to five-half-lives to attain L
FT FT L L
FT FTL FT L



3. Is influenced by renal function FT L FT L L
FT FT L



4. Is directly related to the drug circulating to the target tissues
FT L FT L FT L FT L FT L FTL FT L FT L L
FT FT L




F T L 7. The point in time on the drug concentration curve that indicates the first sign of a therapeutic
L
FT L
FT FT L FT L L
FT FT L L
FT L
FT FT L FT L L
FT L
FT L
FT L
FT L
FT L
FT L
FT




effect is the:
L
FT FT L FT L


1. Minimum adverse effect level FTL FT L FT L



2. Peak of action L
FT L
FT

, 3. Onset of action FTL FT L



4. Therapeutic range L
FT




F T L 8. Phenytoin requires that a trough level be drawn. Peak and trough levels are done:
L
FT FT L FT L L
FT FT L FT L FT L FT L FT L FT L FT L FT L FT L F T L



1. When the drug has a wide therapeutic range FT L FT L FT L FT L FT L FT L FT L



2. When the drug will be administered for a short time only FT L FT L FT L FT L FT L FT L L
FT FT L FT L FT L



3. When there is a high correlation between the dose and saturation of receptor sites FT L FT L FT L FT L FT L L
FT L
FT L
FT L
FT L
FT FT L L
FT FT L



4. To determine if a drug is in the therapeutic range
FT L FT L FT L L
FT FT L L
FT FT L FT L L
FT




F T L F T L 9. A laboratory result indicates that the peak level for a drug is above the minimum toxic concentration.
FT L L
FT L
FT FT L L
FT FT L FT L FT L FT L FT L FT L FT L L
FT L
FT FT L F T L L
T
F




This means that the: L
FT L
FT L
FT




1. Concentration will produce therapeutic effects FT L L
FT L
FT FT L



2. Concentration will produce an adverse response FT L FT L L
FT FT L FT L



3. Time between doses must be shortened L
FT FT L FT L L
FT FT L



4. Duration of action of the drug is too long FT L FT L FT L FT L L
FT FT L FT L FT L




F T L 10. Drugs that are receptor agonists may demonstrate what property?
FT L FT L FT L FT L FT L FT L FT L FT L F T L



1. Irreversible binding to the drug receptor site L
FT L
FT FT L FT L FT L FT L



2. Upregulation with chronic use FT L FT L FT L



3. Desensitization or downregulation with continuous use L
FT L
FT FT L L
FT FT L



4. Inverse relationship between drug concentration and drug action FTL L
FT L
FT FT L L
FT FT L L
FT




F T L 11. Drugs that are receptor antagonists, such as beta blockers, may cause:
FT L FT L FT L FT L FT L FT L FT L FT L FT L FT L F T L



1. Downregulation of the drug receptor L
FT FT L L
FT FT L



2. An exaggerated response if abruptly discontinued FT L FT L FT L L
FT FT L



3. Partial blockade of the effects of agonist drugs FT L FT L FT L L
FT FT L FT L FT L



4. An exaggerated response to competitive drug agonists FT L FT L FT L FT L L
FT FT L




F T L 12. Factors that affect gastric drug absorption include:
L
FT L
FT FT L FT L FT L FT L F T L



1. Liver enzyme activity FT L FT L



2. Protein-binding properties of the drug molecule L
FT FT L L
FT FT L L
FT




3. Lipid solubility of the drug FT L L
FT FT L L
FT




4. Ability to chew and swallow FT L FT L FT L L
FT




F T L 13. Drugs administered via IV:
FT L FT L FT L F T L



1. Need to be lipid soluble in order to be easily absorbed FT L L
FT FT L FT L L
FT FT L FT L FT L FT L FT L



2. Begin distribution into the body immediately FT L FT L L
FT L
FT L
FT




3. Are easily absorbed if they are nonionized L
FT FT L FT L FT L L
FT FT L



4. May use pinocytosis to be absorbed FT L L
FT FT L L
FT FT L




F T L 14. When a medication is added to a regimen for a synergistic effect, the combined effect of the drugs is:
FT L L
FT FT L FT L FT L F T L FTL L
FT FT L FT L FT L FT L FT L L
FT FT L L
FT FT L L
FT L
FT




1. The sum of the effects of each drug individually FT L FT L FT L FT L FT L FT L FT L FT L



2. Greater than the sum of the effects of each drug individually L
FT L
FT FT L FT L FT L FT L FT L L
FT FT L L
FT




3. Less than the effect of each drug individually FT L L
FT L
FT FTL L
FT FT L L
FT




4. Not predictable, as it varies with each individual L
FT FT L FT L FT L FT L FT L L
FT




F T L 15. Which of the following statements about bioavailability is true?
FT L FT L FT L FT L FT L FT L FT L FTL F T L



1. Bioavailability issues are especially important for drugs with narrow therapeutic FT L L
FT L
FT L
FT T
F L L
FT L
FT L
FT T
FL



ranges or sustained-release mechanisms. L
FT FT L FT L FT L




2. All brands of a drug have the same bioavailability. L
FT FT L L
FT FT L L
FT FT L FT L FT L



3. Drugs that are administered more than once a day have greater bioavailability than FT L FTL FTL FT L FT L FT L L
FT L
FT L
FT FT L L
FT L
FT